| Name | 1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-[(1,1-dimethylethyl)dimethylsilyl] |
|---|---|
| Synonyms |
1-(TERT-BUTYLDIMETHYLSILYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLO[2,3-B]PYRIDINE
1-(tert-butyl-dimethyl-silanyl)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 1-(tert-butyldimethylsilanyl)-5-chloro-1H-pyrrolo[2,3-b]pyridine 1-(tert-Butyl-dimethyl-silanyl)-5-butylsulfanyl-1H-pyrrolo[2,3-b]pyridine |
| Density | 1.06g/cm3 |
|---|---|
| Boiling Point | 271.8ºC at 760 mmHg |
| Molecular Formula | C13H19ClN2Si |
| Molecular Weight | 266.84200 |
| Flash Point | 118.2ºC |
| Exact Mass | 266.10100 |
| PSA | 17.82000 |
| LogP | 4.54300 |
| Index of Refraction | 1.534 |
|
~82%
866546-08-9 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED? Patent: WO2005/95400 A1, 2005 ; Location in patent: Page/Page column 342; 343-344 ; WO 2005/095400 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |